Dettaglio Progetto Finanziato

I-BREAKFAST-2

Triple-negative breast cancer is an aggressive form of breast cancer. Our research suggests that combining a nutritional approach known as fasting-mimicking diet with standard treatment may improve outcomes. The BREAKFAST-2 trial is now testing this approach in a larger group of patients. Here, we will study biological markers to predict which patients are most likely to benefit from treatment.